Report Cover

Global Hepatitis B Human Immunoglobulin Market Research Report 2021


The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
    100IU
    200IU
    400IU

Segment by Application
    Measles Prevention
    Prevention of Hepatitis B Virus Infection
    Hepatitis A Virus Infection
    Other

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Biotest
    ADMA Biologics
    Sanquin Blood
    Bio Products Laboratory
    Baxter
    CSL
    Bayer
    Grifols
    Octapharma
    Hualan Biological
    China Biologic
    Tiantan Biologic
    Shuanglin Bio-pharmacy
    Sichuan Yuanda Shuyang
    Shanghai Institute of Biological
    Hualan
    Shanghai RAAS Blood Products
    China Grand Enterprises
    Nanyue Biopharmaceutical
    Boya Biopharmaceutical Group
    Tonglu Biopharmaceutical
    Shandong Taibang Biopharmaceutical
    Guangdong Shuanglin Biopharmaceutical
    Chengdu Rongsheng Pharmaceutical
    Shenzhen Weiguang Biopharmaceutical
    Green Cross (China) Biological Products
    Sinopharm
1 Hepatitis B Human Immunoglobulin Market Overview
    1.1 Product Overview and Scope of Hepatitis B Human Immunoglobulin
    1.2 Hepatitis B Human Immunoglobulin Segment by Type
        1.2.1 Global Hepatitis B Human Immunoglobulin Sales Growth Rate Comparison by Type (2021-2027)
        1.2.2 100IU
        1.2.3 200IU
        1.2.4 400IU
    1.3 Hepatitis B Human Immunoglobulin Segment by Application
        1.3.1 Hepatitis B Human Immunoglobulin Sales Comparison by Application: (2021-2027)
        1.3.2 Measles Prevention
        1.3.3 Prevention of Hepatitis B Virus Infection
        1.3.4 Hepatitis A Virus Infection
        1.3.5 Other
    1.4 Global Hepatitis B Human Immunoglobulin Market Size Estimates and Forecasts
        1.4.1 Global Hepatitis B Human Immunoglobulin Revenue 2016-2027
        1.4.2 Global Hepatitis B Human Immunoglobulin Sales 2016-2027
        1.4.3 Hepatitis B Human Immunoglobulin Market Size by Region: 2016 Versus 2021 Versus 2027

2 Hepatitis B Human Immunoglobulin Market Competition by Manufacturers
    2.1 Global Hepatitis B Human Immunoglobulin Sales Market Share by Manufacturers (2016-2021)
    2.2 Global Hepatitis B Human Immunoglobulin Revenue Market Share by Manufacturers (2016-2021)
    2.3 Global Hepatitis B Human Immunoglobulin Average Price by Manufacturers (2016-2021)
    2.4 Manufacturers Hepatitis B Human Immunoglobulin Manufacturing Sites, Area Served, Product Type
    2.5 Hepatitis B Human Immunoglobulin Market Competitive Situation and Trends
        2.5.1 Hepatitis B Human Immunoglobulin Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Hepatitis B Human Immunoglobulin Players Market Share by Revenue
        2.5.3 Global Hepatitis B Human Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Hepatitis B Human Immunoglobulin Retrospective Market Scenario by Region
    3.1 Global Hepatitis B Human Immunoglobulin Retrospective Market Scenario in Revenue by Region: 2016-2021
    3.2 Global Hepatitis B Human Immunoglobulin Retrospective Market Scenario in Sales by Region: 2016-2021
    3.3 North America Hepatitis B Human Immunoglobulin Market Facts & Figures by Country
        3.3.1 North America Hepatitis B Human Immunoglobulin Sales by Country
        3.3.2 North America Hepatitis B Human Immunoglobulin Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Hepatitis B Human Immunoglobulin Market Facts & Figures by Country
        3.4.1 Europe Hepatitis B Human Immunoglobulin Sales by Country
        3.4.2 Europe Hepatitis B Human Immunoglobulin Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Hepatitis B Human Immunoglobulin Market Facts & Figures by Region
        3.5.1 Asia Pacific Hepatitis B Human Immunoglobulin Sales by Region
        3.5.2 Asia Pacific Hepatitis B Human Immunoglobulin Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Hepatitis B Human Immunoglobulin Market Facts & Figures by Country
        3.6.1 Latin America Hepatitis B Human Immunoglobulin Sales by Country
        3.6.2 Latin America Hepatitis B Human Immunoglobulin Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Hepatitis B Human Immunoglobulin Market Facts & Figures by Country
        3.7.1 Middle East and Africa Hepatitis B Human Immunoglobulin Sales by Country
        3.7.2 Middle East and Africa Hepatitis B Human Immunoglobulin Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Hepatitis B Human Immunoglobulin Historic Market Analysis by Type
    4.1 Global Hepatitis B Human Immunoglobulin Sales Market Share by Type (2016-2021)
    4.2 Global Hepatitis B Human Immunoglobulin Revenue Market Share by Type (2016-2021)
    4.3 Global Hepatitis B Human Immunoglobulin Price by Type (2016-2021)

5 Global Hepatitis B Human Immunoglobulin Historic Market Analysis by Application
    5.1 Global Hepatitis B Human Immunoglobulin Sales Market Share by Application (2016-2021)
    5.2 Global Hepatitis B Human Immunoglobulin Revenue Market Share by Application (2016-2021)
    5.3 Global Hepatitis B Human Immunoglobulin Price by Application (2016-2021)

6 Key Companies Profiled
    6.1 Biotest
        6.1.1 Biotest Corporation Information
        6.1.2 Biotest Description and Business Overview
        6.1.3 Biotest Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
        6.1.4 Biotest Product Portfolio
        6.1.5 Biotest Recent Developments/Updates
    6.2 ADMA Biologics
        6.2.1 ADMA Biologics Corporation Information
        6.2.2 ADMA Biologics Description and Business Overview
        6.2.3 ADMA Biologics Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
        6.2.4 ADMA Biologics Product Portfolio
        6.2.5 ADMA Biologics Recent Developments/Updates
    6.3 Sanquin Blood
        6.3.1 Sanquin Blood Corporation Information
        6.3.2 Sanquin Blood Description and Business Overview
        6.3.3 Sanquin Blood Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
        6.3.4 Sanquin Blood Product Portfolio
        6.3.5 Sanquin Blood Recent Developments/Updates
    6.4 Bio Products Laboratory
        6.4.1 Bio Products Laboratory Corporation Information
        6.4.2 Bio Products Laboratory Description and Business Overview
        6.4.3 Bio Products Laboratory Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Bio Products Laboratory Product Portfolio
        6.4.5 Bio Products Laboratory Recent Developments/Updates
    6.5 Baxter
        6.5.1 Baxter Corporation Information
        6.5.2 Baxter Description and Business Overview
        6.5.3 Baxter Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
        6.5.4 Baxter Product Portfolio
        6.5.5 Baxter Recent Developments/Updates
    6.6 CSL
        6.6.1 CSL Corporation Information
        6.6.2 CSL Description and Business Overview
        6.6.3 CSL Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
        6.6.4 CSL Product Portfolio
        6.6.5 CSL Recent Developments/Updates
    6.7 Bayer
        6.6.1 Bayer Corporation Information
        6.6.2 Bayer Description and Business Overview
        6.6.3 Bayer Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Bayer Product Portfolio
        6.7.5 Bayer Recent Developments/Updates
    6.8 Grifols
        6.8.1 Grifols Corporation Information
        6.8.2 Grifols Description and Business Overview
        6.8.3 Grifols Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
        6.8.4 Grifols Product Portfolio
        6.8.5 Grifols Recent Developments/Updates
    6.9 Octapharma
        6.9.1 Octapharma Corporation Information
        6.9.2 Octapharma Description and Business Overview
        6.9.3 Octapharma Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
        6.9.4 Octapharma Product Portfolio
        6.9.5 Octapharma Recent Developments/Updates
    6.10 Hualan Biological
        6.10.1 Hualan Biological Corporation Information
        6.10.2 Hualan Biological Description and Business Overview
        6.10.3 Hualan Biological Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
        6.10.4 Hualan Biological Product Portfolio
        6.10.5 Hualan Biological Recent Developments/Updates
    6.11 China Biologic
        6.11.1 China Biologic Corporation Information
        6.11.2 China Biologic Hepatitis B Human Immunoglobulin Description and Business Overview
        6.11.3 China Biologic Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
        6.11.4 China Biologic Product Portfolio
        6.11.5 China Biologic Recent Developments/Updates
    6.12 Tiantan Biologic
        6.12.1 Tiantan Biologic Corporation Information
        6.12.2 Tiantan Biologic Hepatitis B Human Immunoglobulin Description and Business Overview
        6.12.3 Tiantan Biologic Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
        6.12.4 Tiantan Biologic Product Portfolio
        6.12.5 Tiantan Biologic Recent Developments/Updates
    6.13 Shuanglin Bio-pharmacy
        6.13.1 Shuanglin Bio-pharmacy Corporation Information
        6.13.2 Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Description and Business Overview
        6.13.3 Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
        6.13.4 Shuanglin Bio-pharmacy Product Portfolio
        6.13.5 Shuanglin Bio-pharmacy Recent Developments/Updates
    6.14 Sichuan Yuanda Shuyang
        6.14.1 Sichuan Yuanda Shuyang Corporation Information
        6.14.2 Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Description and Business Overview
        6.14.3 Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
        6.14.4 Sichuan Yuanda Shuyang Product Portfolio
        6.14.5 Sichuan Yuanda Shuyang Recent Developments/Updates
    6.15 Shanghai Institute of Biological
        6.15.1 Shanghai Institute of Biological Corporation Information
        6.15.2 Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Description and Business Overview
        6.15.3 Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
        6.15.4 Shanghai Institute of Biological Product Portfolio
        6.15.5 Shanghai Institute of Biological Recent Developments/Updates
    6.16 Hualan
        6.16.1 Hualan Corporation Information
        6.16.2 Hualan Hepatitis B Human Immunoglobulin Description and Business Overview
        6.16.3 Hualan Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
        6.16.4 Hualan Product Portfolio
        6.16.5 Hualan Recent Developments/Updates
    6.17 Shanghai RAAS Blood Products
        6.17.1 Shanghai RAAS Blood Products Corporation Information
        6.17.2 Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Description and Business Overview
        6.17.3 Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
        6.17.4 Shanghai RAAS Blood Products Product Portfolio
        6.17.5 Shanghai RAAS Blood Products Recent Developments/Updates
    6.18 China Grand Enterprises
        6.18.1 China Grand Enterprises Corporation Information
        6.18.2 China Grand Enterprises Hepatitis B Human Immunoglobulin Description and Business Overview
        6.18.3 China Grand Enterprises Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
        6.18.4 China Grand Enterprises Product Portfolio
        6.18.5 China Grand Enterprises Recent Developments/Updates
    6.19 Nanyue Biopharmaceutical
        6.19.1 Nanyue Biopharmaceutical Corporation Information
        6.19.2 Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Description and Business Overview
        6.19.3 Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
        6.19.4 Nanyue Biopharmaceutical Product Portfolio
        6.19.5 Nanyue Biopharmaceutical Recent Developments/Updates
    6.20 Boya Biopharmaceutical Group
        6.20.1 Boya Biopharmaceutical Group Corporation Information
        6.20.2 Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Description and Business Overview
        6.20.3 Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
        6.20.4 Boya Biopharmaceutical Group Product Portfolio
        6.20.5 Boya Biopharmaceutical Group Recent Developments/Updates
    6.21 Tonglu Biopharmaceutical
        6.21.1 Tonglu Biopharmaceutical Corporation Information
        6.21.2 Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Description and Business Overview
        6.21.3 Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
        6.21.4 Tonglu Biopharmaceutical Product Portfolio
        6.21.5 Tonglu Biopharmaceutical Recent Developments/Updates
    6.22 Shandong Taibang Biopharmaceutical
        6.22.1 Shandong Taibang Biopharmaceutical Corporation Information
        6.22.2 Shandong Taibang Biopharmaceutical Hepatitis B Human Immunoglobulin Description and Business Overview
        6.22.3 Shandong Taibang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
        6.22.4 Shandong Taibang Biopharmaceutical Product Portfolio
        6.22.5 Shandong Taibang Biopharmaceutical Recent Developments/Updates
    6.23 Guangdong Shuanglin Biopharmaceutical
        6.23.1 Guangdong Shuanglin Biopharmaceutical Corporation Information
        6.23.2 Guangdong Shuanglin Biopharmaceutical Hepatitis B Human Immunoglobulin Description and Business Overview
        6.23.3 Guangdong Shuanglin Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
        6.23.4 Guangdong Shuanglin Biopharmaceutical Product Portfolio
        6.23.5 Guangdong Shuanglin Biopharmaceutical Recent Developments/Updates
    6.24 Chengdu Rongsheng Pharmaceutical
        6.24.1 Chengdu Rongsheng Pharmaceutical Corporation Information
        6.24.2 Chengdu Rongsheng Pharmaceutical Hepatitis B Human Immunoglobulin Description and Business Overview
        6.24.3 Chengdu Rongsheng Pharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
        6.24.4 Chengdu Rongsheng Pharmaceutical Product Portfolio
        6.24.5 Chengdu Rongsheng Pharmaceutical Recent Developments/Updates
    6.25 Shenzhen Weiguang Biopharmaceutical
        6.25.1 Shenzhen Weiguang Biopharmaceutical Corporation Information
        6.25.2 Shenzhen Weiguang Biopharmaceutical Hepatitis B Human Immunoglobulin Description and Business Overview
        6.25.3 Shenzhen Weiguang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
        6.25.4 Shenzhen Weiguang Biopharmaceutical Product Portfolio
        6.25.5 Shenzhen Weiguang Biopharmaceutical Recent Developments/Updates
    6.26 Green Cross (China) Biological Products
        6.26.1 Green Cross (China) Biological Products Corporation Information
        6.26.2 Green Cross (China) Biological Products Hepatitis B Human Immunoglobulin Description and Business Overview
        6.26.3 Green Cross (China) Biological Products Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
        6.26.4 Green Cross (China) Biological Products Product Portfolio
        6.26.5 Green Cross (China) Biological Products Recent Developments/Updates
    6.27 Sinopharm
        6.27.1 Sinopharm Corporation Information
        6.27.2 Sinopharm Hepatitis B Human Immunoglobulin Description and Business Overview
        6.27.3 Sinopharm Hepatitis B Human Immunoglobulin Sales, Revenue and Gross Margin (2016-2021)
        6.27.4 Sinopharm Product Portfolio
        6.27.5 Sinopharm Recent Developments/Updates

7 Hepatitis B Human Immunoglobulin Manufacturing Cost Analysis
    7.1 Hepatitis B Human Immunoglobulin Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Hepatitis B Human Immunoglobulin
    7.4 Hepatitis B Human Immunoglobulin Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Hepatitis B Human Immunoglobulin Distributors List
    8.3 Hepatitis B Human Immunoglobulin Customers

9 Hepatitis B Human Immunoglobulin Market Dynamics
    9.1 Hepatitis B Human Immunoglobulin Industry Trends
    9.2 Hepatitis B Human Immunoglobulin Growth Drivers
    9.3 Hepatitis B Human Immunoglobulin Market Challenges
    9.4 Hepatitis B Human Immunoglobulin Market Restraints

10 Global Market Forecast
    10.1 Hepatitis B Human Immunoglobulin Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Hepatitis B Human Immunoglobulin by Type (2022-2027)
        10.1.2 Global Forecasted Revenue of Hepatitis B Human Immunoglobulin by Type (2022-2027)
    10.2 Hepatitis B Human Immunoglobulin Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Hepatitis B Human Immunoglobulin by Application (2022-2027)
        10.2.2 Global Forecasted Revenue of Hepatitis B Human Immunoglobulin by Application (2022-2027)
    10.3 Hepatitis B Human Immunoglobulin Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Hepatitis B Human Immunoglobulin by Region (2022-2027)
        10.3.2 Global Forecasted Revenue of Hepatitis B Human Immunoglobulin by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables Table 1. Global Hepatitis B Human Immunoglobulin Sales (Litre) Growth Rate Comparison by Type (2021-2027) Table 2. Global Hepatitis B Human Immunoglobulin Sales (Litre) Comparison by Application (2021-2027) Table 3. Global Hepatitis B Human Immunoglobulin Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Hepatitis B Human Immunoglobulin Covered in This Study Table 5. Global Hepatitis B Human Immunoglobulin Sales (Litre) of Key Manufacturers (2016-2021) Table 6. Global Hepatitis B Human Immunoglobulin Sales Share by Manufacturers (2016-2021) Table 7. Global Hepatitis B Human Immunoglobulin Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Hepatitis B Human Immunoglobulin Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Hepatitis B Human Immunoglobulin Average Price (US$/ML) of Key Manufacturers (2016-2021) Table 10. Manufacturers Hepatitis B Human Immunoglobulin Manufacturing Sites and Area Served Table 11. Manufacturers Hepatitis B Human Immunoglobulin Product Type Table 12. Global Hepatitis B Human Immunoglobulin Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Hepatitis B Human Immunoglobulin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis B Human Immunoglobulin as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Hepatitis B Human Immunoglobulin Sales by Region (2016-2021) & (Litre) Table 16. Global Hepatitis B Human Immunoglobulin Sales Market Share by Region (2016-2021) Table 17. Global Hepatitis B Human Immunoglobulin Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Hepatitis B Human Immunoglobulin Sales by Country (2016-2021) & (Litre) Table 19. North America Hepatitis B Human Immunoglobulin Sales Market Share by Country (2016-2021) Table 20. North America Hepatitis B Human Immunoglobulin Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Hepatitis B Human Immunoglobulin Revenue Market Share by Country (2016-2021) Table 22. Europe Hepatitis B Human Immunoglobulin Sales by Country (2016-2021) & (Litre) Table 23. Europe Hepatitis B Human Immunoglobulin Sales Market Share by Country (2016-2021) Table 24. Europe Hepatitis B Human Immunoglobulin Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Hepatitis B Human Immunoglobulin Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Hepatitis B Human Immunoglobulin Sales by Region (2016-2021) & (Litre) Table 27. Asia Pacific Hepatitis B Human Immunoglobulin Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Hepatitis B Human Immunoglobulin Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Hepatitis B Human Immunoglobulin Revenue Market Share by Region (2016-2021) Table 30. Latin America Hepatitis B Human Immunoglobulin Sales by Country (2016-2021) & (Litre) Table 31. Latin America Hepatitis B Human Immunoglobulin Sales Market Share by Country (2016-2021) Table 32. Latin America Hepatitis B Human Immunoglobulin Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Hepatitis B Human Immunoglobulin Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Hepatitis B Human Immunoglobulin Sales by Country (2016-2021) & (Litre) Table 35. Middle East and Africa Hepatitis B Human Immunoglobulin Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Hepatitis B Human Immunoglobulin Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Hepatitis B Human Immunoglobulin Revenue Market Share by Country (2016-2021) Table 38. Global Hepatitis B Human Immunoglobulin Sales (Litre) by Type (2016-2021) Table 39. Global Hepatitis B Human Immunoglobulin Sales Market Share by Type (2016-2021) Table 40. Global Hepatitis B Human Immunoglobulin Revenue (Million US$) by Type (2016-2021) Table 41. Global Hepatitis B Human Immunoglobulin Revenue Share by Type (2016-2021) Table 42. Global Hepatitis B Human Immunoglobulin Price (US$/ML) by Type (2016-2021) Table 43. Global Hepatitis B Human Immunoglobulin Sales (Litre) by Application (2016-2021) Table 44. Global Hepatitis B Human Immunoglobulin Sales Market Share by Application (2016-2021) Table 45. Global Hepatitis B Human Immunoglobulin Revenue (Million US$) by Application (2016-2021) Table 46. Global Hepatitis B Human Immunoglobulin Revenue Share by Application (2016-2021) Table 47. Global Hepatitis B Human Immunoglobulin Price (US$/ML) by Application (2016-2021) Table 48. Biotest Corporation Information Table 49. Biotest Description and Business Overview Table 50. Biotest Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (Million US$), Price (US$/ML) and Gross Margin (2016-2021) Table 51. Biotest Hepatitis B Human Immunoglobulin Product Table 52. Biotest Recent Developments/Updates Table 53. ADMA Biologics Corporation Information Table 54. ADMA Biologics Description and Business Overview Table 55. ADMA Biologics Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (Million US$), Price (US$/ML) and Gross Margin (2016-2021) Table 56. ADMA Biologics Hepatitis B Human Immunoglobulin Product Table 57. ADMA Biologics Recent Developments/Updates Table 58. Sanquin Blood Corporation Information Table 59. Sanquin Blood Description and Business Overview Table 60. Sanquin Blood Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (Million US$), Price (US$/ML) and Gross Margin (2016-2021) Table 61. Sanquin Blood Hepatitis B Human Immunoglobulin Product Table 62. Sanquin Blood Recent Developments/Updates Table 63. Bio Products Laboratory Corporation Information Table 64. Bio Products Laboratory Description and Business Overview Table 65. Bio Products Laboratory Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (Million US$), Price (US$/ML) and Gross Margin (2016-2021) Table 66. Bio Products Laboratory Hepatitis B Human Immunoglobulin Product Table 67. Bio Products Laboratory Recent Developments/Updates Table 68. Baxter Corporation Information Table 69. Baxter Description and Business Overview Table 70. Baxter Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (Million US$), Price (US$/ML) and Gross Margin (2016-2021) Table 71. Baxter Hepatitis B Human Immunoglobulin Product Table 72. Baxter Recent Developments/Updates Table 73. CSL Corporation Information Table 74. CSL Description and Business Overview Table 75. CSL Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (Million US$), Price (US$/ML) and Gross Margin (2016-2021) Table 76. CSL Hepatitis B Human Immunoglobulin Product Table 77. CSL Recent Developments/Updates Table 78. Bayer Corporation Information Table 79. Bayer Description and Business Overview Table 80. Bayer Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (Million US$), Price (US$/ML) and Gross Margin (2016-2021) Table 81. Bayer Hepatitis B Human Immunoglobulin Product Table 82. Bayer Recent Developments/Updates Table 83. Grifols Corporation Information Table 84. Grifols Description and Business Overview Table 85. Grifols Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (Million US$), Price (US$/ML) and Gross Margin (2016-2021) Table 86. Grifols Hepatitis B Human Immunoglobulin Product Table 87. Grifols Recent Developments/Updates Table 88. Octapharma Corporation Information Table 89. Octapharma Description and Business Overview Table 90. Octapharma Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (Million US$), Price (US$/ML) and Gross Margin (2016-2021) Table 91. Octapharma Hepatitis B Human Immunoglobulin Product Table 92. Octapharma Recent Developments/Updates Table 93. Hualan Biological Corporation Information Table 94. Hualan Biological Description and Business Overview Table 95. Hualan Biological Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (Million US$), Price (US$/ML) and Gross Margin (2016-2021) Table 96. Hualan Biological Hepatitis B Human Immunoglobulin Product Table 97. Hualan Biological Recent Developments/Updates Table 98. China Biologic Corporation Information Table 99. China Biologic Description and Business Overview Table 100. China Biologic Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (Million US$), Price (US$/ML) and Gross Margin (2016-2021) Table 101. China Biologic Hepatitis B Human Immunoglobulin Product Table 102. China Biologic Recent Developments/Updates Table 103. Tiantan Biologic Corporation Information Table 104. Tiantan Biologic Description and Business Overview Table 105. Tiantan Biologic Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (Million US$), Price (US$/ML) and Gross Margin (2016-2021) Table 106. Tiantan Biologic Hepatitis B Human Immunoglobulin Product Table 107. Tiantan Biologic Recent Developments/Updates Table 108. Shuanglin Bio-pharmacy Corporation Information Table 109. Shuanglin Bio-pharmacy Description and Business Overview Table 110. Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (Million US$), Price (US$/ML) and Gross Margin (2016-2021) Table 111. Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Product Table 112. Shuanglin Bio-pharmacy Recent Developments/Updates Table 113. Sichuan Yuanda Shuyang Corporation Information Table 114. Sichuan Yuanda Shuyang Description and Business Overview Table 115. Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (Million US$), Price (US$/ML) and Gross Margin (2016-2021) Table 116. Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Product Table 117. Sichuan Yuanda Shuyang Recent Developments/Updates Table 118. Shanghai Institute of Biological Corporation Information Table 119. Shanghai Institute of Biological Description and Business Overview Table 120. Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (Million US$), Price (US$/ML) and Gross Margin (2016-2021) Table 121. Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Product Table 122. Shanghai Institute of Biological Recent Developments/Updates Table 123. Hualan Corporation Information Table 124. Hualan Description and Business Overview Table 125. Hualan Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (Million US$), Price (US$/ML) and Gross Margin (2016-2021) Table 126. Hualan Hepatitis B Human Immunoglobulin Product Table 127. Hualan Recent Developments/Updates Table 128. Shanghai RAAS Blood Products Corporation Information Table 129. Shanghai RAAS Blood Products Description and Business Overview Table 130. Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (Million US$), Price (US$/ML) and Gross Margin (2016-2021) Table 131. Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Product Table 132. Shanghai RAAS Blood Products Recent Developments/Updates Table 133. China Grand Enterprises Corporation Information Table 134. China Grand Enterprises Description and Business Overview Table 135. China Grand Enterprises Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (Million US$), Price (US$/ML) and Gross Margin (2016-2021) Table 136. China Grand Enterprises Hepatitis B Human Immunoglobulin Product Table 137. China Grand Enterprises Recent Developments/Updates Table 138. Nanyue Biopharmaceutical Corporation Information Table 139. Nanyue Biopharmaceutical Description and Business Overview Table 140. Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (Million US$), Price (US$/ML) and Gross Margin (2016-2021) Table 141. Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Product Table 142. Nanyue Biopharmaceutical Recent Developments/Updates Table 143. Boya Biopharmaceutical Group Corporation Information Table 144. Boya Biopharmaceutical Group Description and Business Overview Table 145. Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (Million US$), Price (US$/ML) and Gross Margin (2016-2021) Table 146. Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Product Table 147. Boya Biopharmaceutical Group Recent Developments/Updates Table 148. Tonglu Biopharmaceutical Corporation Information Table 149. Tonglu Biopharmaceutical Description and Business Overview Table 150. Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (Million US$), Price (US$/ML) and Gross Margin (2016-2021) Table 151. Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Product Table 152. Tonglu Biopharmaceutical Recent Developments/Updates Table 153. Shandong Taibang Biopharmaceutical Corporation Information Table 154. Shandong Taibang Biopharmaceutical Description and Business Overview Table 155. Shandong Taibang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (Million US$), Price (US$/ML) and Gross Margin (2016-2021) Table 156. Shandong Taibang Biopharmaceutical Hepatitis B Human Immunoglobulin Product Table 157. Shandong Taibang Biopharmaceutical Recent Developments/Updates Table 158. Guangdong Shuanglin Biopharmaceutical Corporation Information Table 159. Guangdong Shuanglin Biopharmaceutical Description and Business Overview Table 160. Guangdong Shuanglin Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (Million US$), Price (US$/ML) and Gross Margin (2016-2021) Table 161. Guangdong Shuanglin Biopharmaceutical Hepatitis B Human Immunoglobulin Product Table 162. Guangdong Shuanglin Biopharmaceutical Recent Developments/Updates Table 163. Chengdu Rongsheng Pharmaceutical Corporation Information Table 164. Chengdu Rongsheng Pharmaceutical Description and Business Overview Table 165. Chengdu Rongsheng Pharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (Million US$), Price (US$/ML) and Gross Margin (2016-2021) Table 166. Chengdu Rongsheng Pharmaceutical Hepatitis B Human Immunoglobulin Product Table 167. Chengdu Rongsheng Pharmaceutical Recent Developments/Updates Table 168. Shenzhen Weiguang Biopharmaceutical Corporation Information Table 169. Shenzhen Weiguang Biopharmaceutical Description and Business Overview Table 170. Shenzhen Weiguang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (Million US$), Price (US$/ML) and Gross Margin (2016-2021) Table 171. Shenzhen Weiguang Biopharmaceutical Hepatitis B Human Immunoglobulin Product Table 172. Shenzhen Weiguang Biopharmaceutical Recent Developments/Updates Table 173. Green Cross (China) Biological Products Corporation Information Table 174. Green Cross (China) Biological Products Description and Business Overview Table 175. Green Cross (China) Biological Products Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (Million US$), Price (US$/ML) and Gross Margin (2016-2021) Table 176. Green Cross (China) Biological Products Hepatitis B Human Immunoglobulin Product Table 177. Green Cross (China) Biological Products Recent Developments/Updates Table 178. Sinopharm Corporation Information Table 179. Sinopharm Description and Business Overview Table 180. Sinopharm Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (Million US$), Price (US$/ML) and Gross Margin (2016-2021) Table 181. Sinopharm Hepatitis B Human Immunoglobulin Product Table 182. Sinopharm Recent Developments/Updates Table 183. Production Base and Market Concentration Rate of Raw Material Table 184. Key Suppliers of Raw Materials Table 185. Hepatitis B Human Immunoglobulin Distributors List Table 186. Hepatitis B Human Immunoglobulin Customers List Table 187. Hepatitis B Human Immunoglobulin Market Trends Table 188. Hepatitis B Human Immunoglobulin Growth Drivers Table 189. Hepatitis B Human Immunoglobulin Market Restraints Table 190. Global Hepatitis B Human Immunoglobulin Sales Forecast by Type (2022-2027) & (Litre) Table 191. Global Hepatitis B Human Immunoglobulin Sales Market Share Forecast by Type (2022-2027) Table 192. Global Hepatitis B Human Immunoglobulin Revenue Forecast by Type (2022-2027) & (US$ Million) Table 193. Global Hepatitis B Human Immunoglobulin Revenue Market Share Forecast by Type (2022-2027) Table 194. Global Hepatitis B Human Immunoglobulin Sales Forecast by Application (2022-2027) & (Litre) Table 195. Global Hepatitis B Human Immunoglobulin Sales Market Share Forecast by Application (2022-2027) Table 196. Global Hepatitis B Human Immunoglobulin Revenue Forecast by Application (2022-2027) & (US$ Million) Table 197. Global Hepatitis B Human Immunoglobulin Revenue Market Share Forecast by Application (2022-2027) Table 198. Global Hepatitis B Human Immunoglobulin Sales Forecast by Region (2022-2027) & (Litre) Table 199. Global Hepatitis B Human Immunoglobulin Sales Market Share Forecast by Region (2022-2027) Table 200. Global Hepatitis B Human Immunoglobulin Revenue Forecast by Region (2022-2027) & (US$ Million) Table 201. Global Hepatitis B Human Immunoglobulin Revenue Market Share Forecast by Region (2022-2027) Table 202. Research Programs/Design for This Report Table 203. Key Data Information from Secondary Sources Table 204. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Hepatitis B Human Immunoglobulin Figure 2. Global Hepatitis B Human Immunoglobulin Market Share by Type in 2020 & 2027 Figure 3. 100IU Product Picture Figure 4. 200IU Product Picture Figure 5. 400IU Product Picture Figure 6. Global Hepatitis B Human Immunoglobulin Market Share by Application in 2020 & 2027 Figure 7. Measles Prevention Figure 8. Prevention of Hepatitis B Virus Infection Figure 9. Hepatitis A Virus Infection Figure 10. Other Figure 11. Global Hepatitis B Human Immunoglobulin Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Hepatitis B Human Immunoglobulin Market Size 2016-2027 (US$ Million) Figure 13. Global Hepatitis B Human Immunoglobulin Sales 2016-2027 (Litre) Figure 14. Global Hepatitis B Human Immunoglobulin Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 15. Hepatitis B Human Immunoglobulin Sales Share by Manufacturers in 2020 Figure 16. Global Hepatitis B Human Immunoglobulin Revenue Share by Manufacturers in 2020 Figure 17. The Global 5 and 10 Largest Hepatitis B Human Immunoglobulin Players: Market Share by Revenue in 2020 Figure 18. Hepatitis B Human Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 19. Global Hepatitis B Human Immunoglobulin Sales Market Share by Region (2016-2021) Figure 20. Global Hepatitis B Human Immunoglobulin Sales Market Share by Region in 2020 Figure 21. Global Hepatitis B Human Immunoglobulin Revenue Market Share by Region (2016-2021) Figure 22. Global Hepatitis B Human Immunoglobulin Revenue Market Share by Region in 2020 Figure 23. U.S. Hepatitis B Human Immunoglobulin Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. Canada Hepatitis B Human Immunoglobulin Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Germany Hepatitis B Human Immunoglobulin Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. France Hepatitis B Human Immunoglobulin Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. U.K. Hepatitis B Human Immunoglobulin Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Italy Hepatitis B Human Immunoglobulin Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Russia Hepatitis B Human Immunoglobulin Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. China Hepatitis B Human Immunoglobulin Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Japan Hepatitis B Human Immunoglobulin Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. South Korea Hepatitis B Human Immunoglobulin Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. India Hepatitis B Human Immunoglobulin Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Australia Hepatitis B Human Immunoglobulin Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Taiwan Hepatitis B Human Immunoglobulin Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Indonesia Hepatitis B Human Immunoglobulin Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Thailand Hepatitis B Human Immunoglobulin Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Malaysia Hepatitis B Human Immunoglobulin Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Philippines Hepatitis B Human Immunoglobulin Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Vietnam Hepatitis B Human Immunoglobulin Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Mexico Hepatitis B Human Immunoglobulin Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Brazil Hepatitis B Human Immunoglobulin Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Argentina Hepatitis B Human Immunoglobulin Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Turkey Hepatitis B Human Immunoglobulin Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Saudi Arabia Hepatitis B Human Immunoglobulin Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. UAE Hepatitis B Human Immunoglobulin Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Sales Market Share of Hepatitis B Human Immunoglobulin by Type (2016-2021) Figure 48. Sales Market Share of Hepatitis B Human Immunoglobulin by Application (2016-2021) Figure 49. Sales Market Share of Hepatitis B Human Immunoglobulin by Application in 2020 Figure 50. Revenue Share of Hepatitis B Human Immunoglobulin by Application (2016-2021) Figure 51. Revenue Share of Hepatitis B Human Immunoglobulin by Application in 2020 Figure 52. Manufacturing Cost Structure of Hepatitis B Human Immunoglobulin Figure 53. Manufacturing Process Analysis of Hepatitis B Human Immunoglobulin Figure 54. Hepatitis B Human Immunoglobulin Industrial Chain Analysis Figure 55. Channels of Distribution Figure 56. Distributors Profiles Figure 57. Bottom-up and Top-down Approaches for This Report Figure 58. Data Triangulation Figure 59. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us